These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2080215)

  • 1. [Potential cardiotonic agents. 11. Synthesis and cardiovascular effects of 5-alkyl-substituted 2-amino-3-cyano-5- -4-dyl)pyridines].
    Klauschenz E; Hagen V; Hagen A; Heer S
    Pharmazie; 1990 Jul; 45(8):628. PubMed ID: 2080215
    [No Abstract]   [Full Text] [Related]  

  • 2. [Potential cardiotonic agents. 1. Synthesis and pharmacologic properties of 3-cyano-2-oxaalkylamino-5-(4-pyridinyl)pyridines].
    Hagen V; Hagen A; Heer S; Mitzner R; Niedrich H
    Pharmazie; 1989 Jan; 44(1):20-3. PubMed ID: 2727022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Potential cardiotonic agents. 2. Synthesis and pharmacologic properties of 5-(pyri-4-yl)- and 5-phenyl substituted 3-cyano-6-methyl-2-oxaalkylaminopyridines].
    Klauschenz E; Rumler A; Hagen V; Hagen A; Heer S; Mitzner R; Niedrich H
    Pharmazie; 1989 Jan; 44(1):23-5. PubMed ID: 2727023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Potential cardiotonics. 7. Synthesis and cardiovascular effects of 5-(4-pyridinyl)-, 6-methyl-4-(4-pyridinyl) and 6-methyl-5-phenyl-substituted 3-cyano-2-aminoalkylamino-pyridines].
    Hagen V; Rumler A; Klauschenz E; Hagen A; Heer S; Faust G; Mitzner R
    Pharmazie; 1990 Apr; 45(4):240-1. PubMed ID: 2381972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Potential cardiotonic agents. 6. Synthesis and cardiovascular properties of 5-(4-pyridinyl)-, 6-methyl-5-(4-pyridinyl)- and 6-methyl-5-phenyl-substituted 3-cyano-2-oxaalkyoxy-pyridines].
    Hagen V; Klauschenz E; Rumler A; Hagen A; Heer S; Mitzner R; Niedrich H; Lohmann D
    Pharmazie; 1990 Mar; 45(3):189-90. PubMed ID: 2381960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Potential cardiotonics. 9. Synthesis and cardiovascular effects of 2-(pyrid-3-yl)-methylamino-, 2-(3-amino-pyrazolidino)- and 2-hetarylamino-substituted 3-cyan-5-(pyrid-4-yl)-pyridines].
    Roloff B; Schäfer J; Rumler A; Hagen V; Hagen A
    Pharmazie; 1989 Dec; 44(12):859-60. PubMed ID: 2635323
    [No Abstract]   [Full Text] [Related]  

  • 7. [Potential cardiotonic agents. 4. Synthesis, cardiovascular activity, molecular and crystal structure of 5-phenyl- and 4-(4-pyridinyl)-substituted 2(1H)-pyridinethiones].
    Hagen V; Rumler A; Reck G; Hagen A; Labes D; Heer S
    Pharmazie; 1989 Dec; 44(12):809-13. PubMed ID: 2635317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synthesis of 3-substituted 6-methyl-4-pyridyl-2 (1H) pyridones and testing of their cardiovascular action].
    Hanfeld V; Leistner S; Wagner G; Lohmann D; Poppe H; Heer S
    Pharmazie; 1988 Oct; 43(10):677-9. PubMed ID: 3212010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imidazo[1,2-alpha]pyridines. II. Ozonolysis of imidazo[1,2-alpha]pyridines and synthesis of cardiotonic agents.
    Yamanaka M; Suda S; Yoneda N; Ohhara H
    Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):666-74. PubMed ID: 1611679
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of the electrocardiographic effects of equipotent inotropic doses of amrinone and ouabain in isolated hearts of guinea pigs].
    Furlan CC; Tucci PJ
    Arq Bras Cardiol; 1985 Jul; 45(1):1-5. PubMed ID: 3833121
    [No Abstract]   [Full Text] [Related]  

  • 11. [Potential cardiotonic agents. 8. 2-acyloxyalkylamino-, 2-acyloxyalkoxy-, and 2-acylaminoalkylamino-3-cyan-5-(pyrid-4-yl) pyridine].
    Hagen V; Klauschenz E; Rumler A; Niedrich H; Hagen A; Heer S; Mitzner R
    Pharmazie; 1990 May; 45(5):343-5. PubMed ID: 2395896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,4-trans-4-Aryl-3-(1-pyridinio)-1,2,3,4-tetrahydropyridine-6-thiolates--new group of potential cardiotonic drugs.
    Krauze A; Vītoliņa R; Garaliene V; Sīle L; Klusa V; Duburs G
    Eur J Med Chem; 2005 Nov; 40(11):1163-7. PubMed ID: 15927309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Potential cardiotonics. 5. Preparation and properties of 6-unsubstituted and 6-methyl-substituted 3-cyan-5-(pyrid-4-yl)pyridine].
    Roloff B; Hagen V; Hagen A; Mitzner R; Köppel H
    Pharmazie; 1989 Sep; 44(9):643-4. PubMed ID: 2608713
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synthesis and positive inotropic action of some 5-substituted 5H-(1)benzopyrano(4,3-b)pyridines].
    Heber D; Ravens U
    Arzneimittelforschung; 1985; 35(11):1624-6. PubMed ID: 4091865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and positive inotropic activity of several 5-aminopyrido[2,3-d]pyrimidines. Part 5: Compounds with positive inotropic activity.
    Heber D; Ravens U; Schulze T
    Pharmazie; 1993 Jul; 48(7):509-13. PubMed ID: 8415847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo assessment of the cardiovascular effects of the cardiotonic drug MDL 19205.
    Roebel LE; Dage RC; Cheng HC; Woodward JK
    J Cardiovasc Pharmacol; 1984; 6(1):43-9. PubMed ID: 6199610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
    Yamashita S; Hosokawa T; Kojima M; Mori T; Yabuuchi Y
    Arzneimittelforschung; 1984; 34(3A):342-6. PubMed ID: 6331464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo cardiotonic activity of aryl- and pyridyl-substituted fused imidazoles.
    Andreani A; Leoni A; Morigi R; Bossa R; Chiericozzi M; Galatulas I
    Arzneimittelforschung; 1998 Mar; 48(3):232-5. PubMed ID: 9553678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The cardiovascular effect of Cordemcura on various animal models in vivo].
    Rohde E; Muschick P; Modersohn D; Landmann H; Löwe H
    Pharmazie; 1986 Mar; 41(3):194-5. PubMed ID: 3714794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.